Overview
Beverly Kocarnik is an Endocrinologist in Seattle, Washington. Dr. Kocarnik is rated as an Experienced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Thyroid Storm, Hyperthyroidism, Type 2 Diabetes (T2D), and Postmenopausal Osteoporosis.
Her clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
904 7th Ave Fl 7, Seattle, WA 98104
Additional Areas of Focus
Dr. Kocarnik has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Anthony Desantis is an Endocrinologist in Seattle, Washington. Dr. Desantis is rated as an Advanced provider by MediFind in the treatment of Juvenile Primary Osteoporosis. His top areas of expertise are Hyperparathyroidism, Pituitary Tumor, Parathyroid Hyperplasia, and Familial Isolated Hyperparathyroidism.
Franciscan Endocrine Associates At St. Michael
Hope Torregosa, MD is a board-certified endocrinologist with medical interest in diabetes mellitus, thyroid disease, pituitary and adrenal disease, osteoporosis and mineral disease, general endocrinology, fine-needle aspiration, and thyroid biopsy and ultrasound.Dr. Torregosa tailors her medical care to the needs of each individual patient, with a focus on empowering patients' knowledge and action on their health.Dr. Torregosa is a member of the Endocrine Society, American Association of Clinical Endocrinologists and American Thyroid Association. Dr. Torregosa is rated as a Distinguished provider by MediFind in the treatment of Juvenile Primary Osteoporosis. Her top areas of expertise are Parathyroid Hyperplasia, Neonatal Severe Hyperparathyroidism, Familial Isolated Hyperparathyroidism, and Osteitis Fibrosa.
Gme Office University Of Washington
Richard Failor is an Endocrinologist in Seattle, Washington. Dr. Failor is rated as a Distinguished provider by MediFind in the treatment of Juvenile Primary Osteoporosis. His top areas of expertise are Pituitary Tumor, Anaplastic Thyroid Cancer, Thyroid Cancer, and Follicular Thyroid Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Diabetic NephropathyDr. Kocarnik isExperienced. Learn about Diabetic Nephropathy.
- Graves DiseaseDr. Kocarnik isExperienced. Learn about Graves Disease.
- HyperparathyroidismDr. Kocarnik isExperienced. Learn about Hyperparathyroidism.
- HyperthyroidismDr. Kocarnik isExperienced. Learn about Hyperthyroidism.
- Juvenile Primary OsteoporosisDr. Kocarnik isExperienced. Learn about Juvenile Primary Osteoporosis.
- Maturity Onset Diabetes of the YoungDr. Kocarnik isExperienced. Learn about Maturity Onset Diabetes of the Young.